Drug Combination Details
General Information of the Combination (ID: C16373) | |||||
---|---|---|---|---|---|
Name | Levosimendan NP Info | + | Esmolol Drug Info | ||
Structure |
![]() |
+ |
![]() |
||
Disease |
Cardiogenic shock
[ICD-11: MG40]
|
Investigative | [1] |
Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
---|---|---|---|---|---|---|
α. Decreasing Adverse Drug Reaction by This Combination | ||||||
Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
Experiment 1 Reporting the Effect of This Combination | [1] | |||||
In-vivo Model | A case report | |||||
Experimental
Result(s) |
levosimendan in combination with a beta-adrenergic antagonist may have beneficial effects in patients with cardiogenic shock who exhibit tachycardia in response to inotropic agents. |
References | ||||
---|---|---|---|---|
Reference 1 | Treatment of cardiogenic shock with levosimendan in combination with beta-adrenergic antagonists. Br J Anaesth. 2005 Nov;95(5):648-50. |
